Disease / condition

Paronychia,Epidermal Growth Factor Receptor Inhibitor clinical trials

Free access to 2 studies·1+ countries·Updated daily
2
Total trials
1+
Countries
2+
Sponsors
N/A
Recruiting
By phase
N/A2
By status
Completed2
Top countries
Taiwan2
Top sponsors
Chang Gung Memoria...1
Taipei Medical Uni...1
Recent trials
Latest clinical trials for Paronychia,Epidermal Growth Factor Receptor Inhibitor
NCT06411093Completed
Efficacy and Safety of Kinesiology Tape Wrapping for Paronychia Induced by Epidermal Growth Factor Receptor Inhibitors
Chang Gung Memorial HospitalTaiwan
NCT05165082Completed
The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study
Taipei Medical University WanF...Taiwan
About this record

Access comprehensive clinical trial information for Paronychia,Epidermal Growth Factor Receptor Inhibitor through Pure Global AI's free database. This collection includes 2 clinical trials across multiple phases including N/A.

Research for Paronychia,Epidermal Growth Factor Receptor Inhibitor is being conducted in Taiwan and more. Leading sponsors include Chang Gung Memorial Hospital and Taipei Medical University WanFang Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 2 clinical trials studying Paronychia,Epidermal Growth Factor Receptor Inhibitor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 1+ countries.

Top research sponsors include Chang Gung Memorial Hospital, Taipei Medical University WanFang Hospital, among others.